able glp 1 GLP-1 Drug Side Effects May Be Tackled with More Mechanistic Studies If you or a loved

GLP-1 receptor agonists such as liraglutide, semaglutide, and dulaglutide have shown significant reductions in major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke, primarily in people with established cardiovascular disease or high cardiovascular risk

Yanovski, S.Z

Tirzepatide products unaffected Only semaglutide is losing patent protection

Convenient for daily supplementation

BPC (1,000 mcg) exerts its regenerative activity through VEGF-mediated angiogenesis supporting new capillary formation in healing tissue, growth hormone receptor upregulation amplifying fibroblast collagen synthesis and connective tissue repair, direct stabilization and restoration of intestinal epithelial tight junction proteins protecting and repairing the gut barrier from inflammatory and chemical damage, nitric oxide pathway activation supporting vascular and tissue perfusion, and antioxidant and inflammatory-modulating activity across multiple tissue compartments